This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

ACADIA Pharmaceuticals Reports Second Quarter 2012 Financial Results

Stocks in this article: ACAD

ACADIA PHARMACEUTICALS INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except per share amounts)

(Unaudited)

               

Three Months Ended June 30,

Six Months Ended June 30,

2012

2011

2012

2011

 
 
Collaborative revenues $ 599 $ 460 $ 1,049 $ 895
 
Operating expenses
Research and development (includes stock-based compensation of $154, $134, $293 and $255, respectively) 4,472 4,315 9,493 8,727
General and administrative (includes stock-based compensation of $324, $279, $598 and $534, respectively)   1,556     2,729     3,216     4,613  
Total operating expenses   6,028     7,044     12,709     13,340  
Loss from operations (5,429 ) (6,584 ) (11,660 ) (12,445 )
Interest income, net   10     28     23     56  
Net loss $ (5,419 ) $ (6,556 ) $ (11,637 ) $ (12,389 )
Net loss per common share, basic and diluted $ (0.10 ) $ (0.12 ) $ (0.22 ) $ (0.24 )

Weighted average common shares outstanding, basic and diluted

  52,961     52,677     52,932     51,535  
 

ACADIA PHARMACEUTICALS INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands)

(Unaudited)

       

June 30,

2012

December 31,

2011(1)

 
Assets
Cash, cash equivalents, and investment securities $ 21,349 $ 31,048
Prepaid expenses, receivables and other current assets   426   901
Total current assets 21,775 31,949
Property and equipment, net, and other assets   99   165
Total assets $ 21,874 $ 32,114
Liabilities and Stockholders’ Equity
Accounts payable, accrued expenses and other current liabilities $ 5,995 $ 5,496
Current portion of deferred revenue   765   669
Total current liabilities 6,760 6,165
Long-term portion of deferred revenue   2,406   2,587
Total liabilities 9,166 8,752
Stockholders’ equity   12,708   23,362
Total liabilities and stockholders’ equity $ 21,874 $ 32,114
 
(1)     The condensed consolidated balance sheet at December 31, 2011 has been derived from the audited financial statements at such date but does not include all of the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements.




3 of 4

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,164.95 -251.90 -1.45%
S&P 500 1,994.99 -26.26 -1.30%
NASDAQ 4,635.24 -48.1670 -1.03%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs